Literature DB >> 2363131

Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes.

U Budde1, R Schneppenheim, H Plendl, J Dent, Z M Ruggeri, T S Zimmerman.   

Abstract

Two methods for visualization of vWf multimers were compared with respect to sensitivity and detection of normal vWf and vWd variants IIA, IIB, IIC, IID, IIE, and IIF. Autoradiography and luminography after electrotransfer of vWf multimers onto nitrocellulose showed comparable sensitivity with vWf:Ag detectable after 1:500 dilution of normal plasma. The least sensitive method was luminography in agarose gels with vWf:Ag detectable after 1:300 dilution of normal plasma. No difference existed in the banding patterns of plasmas from patients with variant vWd.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2363131

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  20 in total

1.  Von Willebrand factor regulates complement on endothelial cells.

Authors:  Damien G Noone; Magdalena Riedl; Fred G Pluthero; Mackenzie L Bowman; M Kathryn Liszewski; Lily Lu; Yi Quan; Steve Balgobin; Reinhard Schneppenheim; Sonja Schneppenheim; Ulrich Budde; Paula James; John P Atkinson; Nades Palaniyar; Walter H A Kahr; Christoph Licht
Journal:  Kidney Int       Date:  2016-05-25       Impact factor: 10.612

2.  Analysis of von Willebrand factor multimers using a commercially available enhanced chemiluminescence kit.

Authors:  A M Cumming; R T Wensley
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

3.  Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura.

Authors:  S Kinoshita; A Yoshioka; Y D Park; H Ishizashi; M Konno; M Funato; T Matsui; K Titani; H Yagi; M Matsumoto; Y Fujimura
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

4.  Discrepant platelet and plasma von Willebrand factor in von Willebrand disease patients with p.Pro2808Leufs*24.

Authors:  M L Bowman; F G Pluthero; A Tuttle; L Casey; L Li; H Christensen; K S Robinson; D Lillicrap; W H A Kahr; P James
Journal:  J Thromb Haemost       Date:  2017-06-06       Impact factor: 5.824

5.  Quantification of perioperative changes in von Willebrand factor and factor VIII during elective orthopaedic surgery in normal individuals.

Authors:  A Kahlon; J Grabell; A Tuttle; D Engen; W Hopman; D Lillicrap; P James
Journal:  Haemophilia       Date:  2013-05-28       Impact factor: 4.287

6.  Autosomal dominant C1149R von Willebrand disease: phenotypic findings and their implications.

Authors:  Almudena Pérez-Rodríguez; Aranzazu García-Rivero; Esther Lourés; Maria Fernanda López-Fernández; Angela Rodríguez-Trillo; Javier Batlle
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

7.  Increased von Willebrand factor antigen and high molecular weight multimers in sickle cell disease associated with nocturnal hypoxemia.

Authors:  Suba Krishnan; Jamie Siegel; Gene Pullen; Megan Hevelow; Carlton Dampier; Marie Stuart
Journal:  Thromb Res       Date:  2008-01-29       Impact factor: 3.944

Review 8.  Inactivation of viruses in fresh-frozen plasma.

Authors:  J U Wieding; P Hellstern; M Köhler
Journal:  Ann Hematol       Date:  1993-12       Impact factor: 3.673

9.  Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease.

Authors:  Larry J Suva; Eric Hartman; Joshua D Dilley; Susan Russell; Nisreen S Akel; Robert A Skinner; William R Hogue; Ulrich Budde; Kottayil I Varughese; Taisuke Kanaji; Jerry Ware
Journal:  Am J Pathol       Date:  2008-01-10       Impact factor: 4.307

10.  Two newborn-onset patients of Upshaw-Schulman syndrome with distinct subsequent clinical courses.

Authors:  Saori Tanabe; Hideo Yagi; Toshiyuki Kimura; Ayami Isonishi; Seiji Kato; Yoko Yoshida; Masaki Hayakawa; Masanori Matsumoto; Shinsuke Ohtaki; Yukihiro Takahashi; Yoshihiro Fujimura
Journal:  Int J Hematol       Date:  2012-11-28       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.